SNWV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sanuwave Health Inc (SNWV) is not a strong buy at the moment for a beginner investor with a long-term focus. The lack of positive trading signals, weak financial performance, and absence of strong catalysts make it prudent to hold off on investing in this stock currently.
The MACD is positive but contracting, RSI is neutral at 53.389, and moving averages are converging, suggesting no strong trend. The stock is trading near its pivot level of 18.852, with resistance at 20.544 and support at 17.159. Overall, the technical indicators do not suggest a strong buy signal.
The company has a favorable revenue outlook for FY26 despite reimbursement disruptions, and Q4 2025 revenue increased by 26.81% YoY.
Additionally, there are no significant insider or hedge fund trading trends, no recent news, and no recent congress trading data.
In Q4 2025, revenue increased by 26.81% YoY to $13.09M. However, net income dropped significantly by -142.25% YoY to $6.11M, EPS fell by -101.16% YoY to 0.02, and gross margin declined by 5.11% to 71.86%. These results indicate weak profitability despite revenue growth.
Roth Capital analyst Kyle Bauser lowered the price target from $53 to $47 but maintained a Buy rating. The FY26 revenue outlook of $51M-$55M missed consensus estimates of $58M but is seen as favorable given reimbursement disruptions.
